Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

F. Garway‐Heath, David; P. Crabb, David; Bunce, Catey; Lascaratos, Gerassimos; Amalfitano, Francesca; Anand, Nitin; Azuara‐Blanco, Augusto; Bourne, Rupert; C. Broadway, David; A Cunliffe, I; P. Diamond, Jeremy; G Fraser, Scott; A. Ho, Tuan; R. Martin, Keith; McNaught, Andrew; Negi, Anil; Patel, Krishna; A. Russell, Richard; Shah, Ameet; G. Spry, Paul; SUZUKI, Katsuyoshi; T. White, Edward; Wormald, Richard; Xing, Wen; Zeyen, Thierry

doi:10.1016/s0140-6736(14)62111-5

Public

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

Published in The Lancet • Dec 19, 2014

Authors:

David F. Garway‐Heath

David P. Crabb

Catey Bunce

Abstract

BACKGROUND: Treatments for open-angle glaucoma aim to prevent vision loss through lowering of intraocular pressure, but to our knowledge no placebo-controlled trials have assessed visual function preservation, and the observation periods of previous (unmasked) trials have typically been at least 5 y...

Subject

Medicine

Latanoprost

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!